Patent ID: 11866498
Assignee: GENENTECH, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 5:
6. The bispecific antigen-binding molecule of claim 5, wherein:
(a) the VHA region comprises the amino acid sequence of SEQ ID NO: 7, and the VLA region comprises the amino acid sequence of SEQ ID NO: 8;
(b) the VHB1 region comprises the amino acid sequence of SEQ ID NO: 24, and the VLB1 region comprises the amino acid sequence of SEQ ID NO: 27; and
(c) the VHB2 region comprises the amino acid sequence of SEQ ID NO: 24, and the VLB2 region comprises the amino acid sequence of SEQ ID NO: 27.